BRCA2 and cancer: Extended data on BRCA2 splicing in the presence of different PVs, to be collected by large-scale RNA sequencing, may confirm a previously suggested, potentially tissue-specific role of splice variants in cancer development, as discussed in the context of BRCA2 PV carrier status for breast, ovarian, and pancreatic cancer [50,51].